These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15369649)

  • 1. Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics? A systematic review.
    Waterman EJ; Magee LA; Lim KI; Skoll A; Rurak D; von Dadelszen P
    Hypertens Pregnancy; 2004; 23(2):155-69. PubMed ID: 15369649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
    Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
    BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
    Magee LA; Cham C; Waterman EJ; Ohlsson A; von Dadelszen P
    BMJ; 2003 Oct; 327(7421):955-60. PubMed ID: 14576246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    Sridharan K; Sequeira RP
    Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.
    Shekhar S; Gupta N; Kirubakaran R; Pareek P
    BJOG; 2016 Jan; 123(1):40-7. PubMed ID: 26113232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
    Plouin PF; Breart G; Maillard F; Papiernik E; Relier JP
    Br J Obstet Gynaecol; 1988 Sep; 95(9):868-76. PubMed ID: 3056503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dihydralazine on the fetus in the treatment of maternal hypertension.
    Vink GJ; Moodley J; Philpott RH
    Obstet Gynecol; 1980 Apr; 55(4):519-22. PubMed ID: 7366909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flipside of hydralazine in pregnancy: A systematic review and meta-analysis.
    Antza C; Dimou C; Doundoulakis I; Akrivos E; Stabouli S; Haidich AB; Goulis DG; Kotsis V
    Pregnancy Hypertens; 2020 Jan; 19():177-186. PubMed ID: 32044579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs in pregnancy. Antihypertensives.
    Magee LA
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):827-45. PubMed ID: 11800527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PP088. Oral antihypertensive therapy for severe hypertension in pregnancy.
    Firoz T; Magee LA; Lalani S; Sawchuck D; Payne B; Vidler M; Gordon R; von Dadelszen P;
    Pregnancy Hypertens; 2012 Jul; 2(3):288. PubMed ID: 26105410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of antihypertensives for treatment of pregnancy hypertension.
    Magee LA; Abdullah S
    Expert Opin Drug Saf; 2004 Jan; 3(1):25-38. PubMed ID: 14680459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
    van de Vusse D; Mian P; Schoenmakers S; Flint RB; Visser W; Allegaert K; Versmissen J
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1763-1776. PubMed ID: 36104450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute-onset hypertension in pregnancy: A network meta-analysis of randomized controlled trials comparing anti-hypertensives and route of administration.
    Bhat AD; Keasler PM; Kolluru L; Dombrowski MM; Palanisamy A; Singh PM
    Pregnancy Hypertens; 2023 Dec; 34():74-82. PubMed ID: 37857042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
    Baggio MR; Martins WP; Calderon AC; Berezowski AT; Marcolin AC; Duarte G; Cavalli RC
    Ultrasound Med Biol; 2011 Jan; 37(1):53-8. PubMed ID: 21084154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating hypertension in women of child-bearing age and during pregnancy.
    Magee LA
    Drug Saf; 2001; 24(6):457-74. PubMed ID: 11368252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
    Raheem IA; Saaid R; Omar SZ; Tan PC
    BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
    Plouin PF; Bréart G; Maillard F; Papiernik E; Relier JP
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):952-5. PubMed ID: 3116996
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.